added approximately 11% to its price, while its volume exceeded 640 thousand shares traded.Looks like APNT has started its progressive move after the conference on Oct. 5, when the company’s shareholders approved the proposal to increase the authorized capital stock and authorized common shares. The good news for Applied Nanotech continued when it reported the company was to exhibit some of its key nanotechnology advancements in the USA, Europe and Israel.
Obviously, encouraged by the positive announcements, traders have decided to invest in APNT and the gain has begun.
Applied Nanotech Holdings, Inc. is a premier research and commercialization organization focused on solving problems at the molecular level. Historically, the company used to trade lower, though at the beginning of this month APNT entered an uptrend.[BANNER]
According to the company’s quarterly report, its revenues have increased as compared to the previous period, though APNT has suffered higher research and development expenses. The company’s assets are lower than its liabilities and its stockholders’ equity has decreased.
The management expects to achieve profitability during this year and states that its current cash balances, along with the expected revenue sources, will “enable us to operate well into the second quarter of 2011”. However, the team claims that at its present level of activity, “it is not possible for us to achieve profitability without license fees” and the company’s research revenue should more than double to get any profit.
As Applied Nanotech expects to continue to incur substantial research and development expenses, the company keeps searching for additional funds. In the meantime, investors should carefully observe the future movement of APNT stock.
